- Home
- BCYC vs IMOS Comparison
BCYC vs IMOS Comparison
Compare BCYC & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- IMOS
- Stock Information
- Founded
- BCYC 2009
- IMOS 1997
- Country
- BCYC United Kingdom
- IMOS Taiwan
- Employees
- BCYC N/A
- IMOS N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- BCYC Health Care
- IMOS Technology
- Exchange
- BCYC Nasdaq
- IMOS Nasdaq
- Market Cap
- BCYC 529.8M
- IMOS 534.3M
- IPO Year
- BCYC 2019
- IMOS N/A
- Fundamental
- Price
- BCYC $7.10
- IMOS $15.79
- Analyst Decision
- BCYC Buy
- IMOS
- Analyst Count
- BCYC 12
- IMOS 0
- Target Price
- BCYC $22.91
- IMOS N/A
- AVG Volume (30 Days)
- BCYC 261.8K
- IMOS 20.4K
- Earning Date
- BCYC 08-08-2025
- IMOS 08-12-2025
- Dividend Yield
- BCYC N/A
- IMOS 4.08%
- EPS Growth
- BCYC N/A
- IMOS N/A
- EPS
- BCYC N/A
- IMOS 0.01
- Revenue
- BCYC $19,281,000.00
- IMOS $777,452,000.00
- Revenue This Year
- BCYC $7.35
- IMOS $3.12
- Revenue Next Year
- BCYC N/A
- IMOS $3.25
- P/E Ratio
- BCYC N/A
- IMOS $93.54
- Revenue Growth
- BCYC N/A
- IMOS 0.89
- 52 Week Low
- BCYC $6.10
- IMOS $12.78
- 52 Week High
- BCYC $28.67
- IMOS $23.85
- Technical
- Relative Strength Index (RSI)
- BCYC 37.11
- IMOS 36.78
- Support Level
- BCYC $7.25
- IMOS $15.06
- Resistance Level
- BCYC $7.68
- IMOS $15.60
- Average True Range (ATR)
- BCYC 0.42
- IMOS 0.35
- MACD
- BCYC -0.07
- IMOS -0.16
- Stochastic Oscillator
- BCYC 12.80
- IMOS 24.66
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.